Dexmedetomidine vs. Propofol for Cataract Surgery
- Conditions
- Cataract
- Interventions
- Registration Number
- NCT00786370
- Lead Sponsor
- The Cooper Health System
- Brief Summary
The use of dexmedetomidine in cataract surgery is still limited and to date only one study has examined anesthetic technique in this patient population. This pilot study will therefore compare the use of dexmedetomidine and propofol in subjects undergoing cataract surgery. The primary endpoint will be based on simple cardiorespiratory measures often associated with complications from sedation as well as assessment of the achieved sedation by the attending anesthesiologist and surgeon.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 24
- Normal renal function
- No chronic use of narcotics
- ASA PS1-3
- Males or females age 18 or older
- Liver disease (Child Pugh classification 1-3)
- History of chronic use of sedatives, narcotics, alcohol or illicit drugs or allergy to any the study medications
- History of 1st and 2nd degree heart block (not paced)
- Any patient with EF < 30%
- Patients with active seizure history
- Pregnant patients (women of child bearing potential will have a preoperative pregnancy test as is standard of practice)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Propofol Propofol - Dexmedetomidine Dexemedetomidine - Dexmedetomidine dexmedetomidine -
- Primary Outcome Measures
Name Time Method To compare select cardiorespiratory effects of dexmedetomidine sedation to those of propofol sedation in patients undergoing cataract surgery. 1 day
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Cooper University Hospital
🇺🇸Camden, New Jersey, United States